<?xml version="1.0" encoding="UTF-8"?>
<p id="P18">Using modified Fluorescent Antibody Virus Neutralisation (mFAVN) assays, neutralising antibodies to LBV were detected in all continental and island locations (
 <xref ref-type="table" rid="T1">Table 1</xref>), yet seroprevalences showed significant variation by geographical location. A strikingly low LBV seroprevalence relative to other locations was observed in the Annobón population (χ
 <sup>2</sup> = 66.5, 
 <italic>p</italic> &lt; 0.001), but seroprevalences in Bioko, São Tomé and Príncipe were not significantly different from mainland populations. Excluding Annobón and populations with sample sizes that were insufficient to allow a reliable seroprevalence to be calculated (Malawi, Zambia and Uganda; n = 12, 9 and 4, respectively), the mean LBV seroprevalence was 34% (95% CI: 32–37%) and the range of adult seroprevalences was 24–51% (
 <xref ref-type="supplementary-material" rid="SD2">Supplementary Data 1</xref>). In the Annobón population, neutralising antibodies to LBV were detected in 1 of 72 (1.4%, 0.0–7.5%) bats sampled in 2010 
 <sup>
  <xref ref-type="bibr" rid="R24">24</xref>
 </sup>, and in 6 of 49 (14%, 7–27%) bats sampled in 2011.
</p>
